| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/09/2008 | WO2008121563A2 Modified fgf-21 polypeptides and their uses |
| 10/09/2008 | WO2008121442A2 Pa28-gamma regulation in cells |
| 10/09/2008 | WO2008121437A2 Trophinin-binding peptides and uses thereof |
| 10/09/2008 | WO2008121435A2 Methods for generating novel stabilized proteins |
| 10/09/2008 | WO2008121127A2 Methods of use of polycomb homologue mel-18 |
| 10/09/2008 | WO2008121009A1 Modified adiponectin proteins |
| 10/09/2008 | WO2008121007A1 Novel saratan polypeptides and polynucleotides and methods of use thereof |
| 10/09/2008 | WO2008120801A1 Method of producing antithrombin composition |
| 10/09/2008 | WO2008120410A1 Genes having activity of promoting endoreduplication |
| 10/09/2008 | WO2008120263A2 Prokineticins receptors antagonists, derivatives and uses thereof |
| 10/09/2008 | WO2008120240A1 Anti diabetic protein |
| 10/09/2008 | WO2008119970A1 Functional protein crystals containing a core nano-particle and uses thereof |
| 10/09/2008 | WO2008119735A1 Method of producing hydroxy fatty acids |
| 10/09/2008 | WO2008119567A2 Cross-species-specific cd3-epsilon binding domain |
| 10/09/2008 | WO2008119566A2 Cross-species-specific bispecific binders |
| 10/09/2008 | WO2008119565A2 Cross-species-specific binding domain |
| 10/09/2008 | WO2008119545A1 Human fc gamma receptor iii |
| 10/09/2008 | WO2008119358A2 Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions |
| 10/09/2008 | WO2008119356A1 The use of a type ii transmembrane protein designated fibcd1 as an endocytosis receptor of acetylated compounds |
| 10/09/2008 | WO2008119258A1 A recombinant adenovirus useful for treating malignancy overexpressing proto-oncogene neu/erbb2 |
| 10/09/2008 | WO2008119186A1 Method for selective fractionation of growth factors from dairy products |
| 10/09/2008 | WO2008119185A1 Process for the manufacture of a dairy-based anti-inflammatory composition |
| 10/09/2008 | WO2008119170A1 Method of determining risk of scoliosis |
| 10/09/2008 | WO2008119110A1 Treatment of obesity |
| 10/09/2008 | WO2008090285A3 New peptides and polypeptides with improved stability useful in the regeneration of the nervous system |
| 10/09/2008 | WO2008089053A3 Gp100-specific t cell receptors and related materials and methods of use |
| 10/09/2008 | WO2008086449A3 Synthetic osteopontin peptides and methods of use |
| 10/09/2008 | WO2008085551A3 Smallpox monoclonal antibody |
| 10/09/2008 | WO2008079705A3 Acyl-transferase |
| 10/09/2008 | WO2008068534A3 Crystal structure of a betal -adremergi c receptor and uses thereof |
| 10/09/2008 | WO2008057637A3 Methods of increasing secretion of polypeptides having biological activity |
| 10/09/2008 | WO2008042469A3 Knockout mice for different genes and their use for gene characterizatio |
| 10/09/2008 | WO2008038296A3 Recombinant calcitonin fused to interleukin-2 |
| 10/09/2008 | WO2008022019A3 Promiscuous her-2/neu cd4 t cell epitopes |
| 10/09/2008 | WO2007149062A3 Bioactive fus1 peptides and nanoprticle-polypeptide complexes |
| 10/09/2008 | WO2007146038A3 Albumin fusion proteins |
| 10/09/2008 | WO2007101028A3 Method to produce enzymatically active recombinant endonucleases |
| 10/09/2008 | WO2007095151A3 Nerve regeneration employing keratin biomaterials |
| 10/09/2008 | WO2007089805A3 Anti-hypertrophic effects and inotropic effects of picot |
| 10/09/2008 | WO2007084740A3 Tat-030 and methods of assessing and treating cancer |
| 10/09/2008 | WO2007067616A3 Uses of myostatin antagonists |
| 10/09/2008 | WO2006116423A3 Compositions and methods for cancer immunotherapy |
| 10/09/2008 | WO2004065561A3 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same |
| 10/09/2008 | US20080250532 Promoter sequence for use in controlled expression of heterologous polypeptides in plant endosperm |
| 10/09/2008 | US20080250514 Expression Systems Using Mammalian Beta-Actin Promoter |
| 10/09/2008 | US20080249451 Replacement of cystine disulfide bonds with lanthionine residues; incubation keratin in solvent |
| 10/09/2008 | US20080249293 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 10/09/2008 | US20080249288 Recombinantly preparing antibody fusion for targeting and/or treating metabolic disorders |
| 10/09/2008 | US20080249284 Gene encoding labyrinthin, a marker for cancer |
| 10/09/2008 | US20080249283 Human leukocyte antigen amino acid sequences which recognize hepatitis viral epitopes; vaccine development; viricides |
| 10/09/2008 | US20080249083 isolated nucleic acids coding for novel glutaminyl-peptide cyclotransferase-like proteins (QPCTLs); isoenzymes; useful for the discovery of new therapeutic agents, for measuring cyclase activity; Alzheimer's disease, Familial British Dementia, Familial Danish Dementia, Down Syndrome, Huntington's disease |
| 10/09/2008 | US20080249081 Compounds for the treatment of pain and screening methods therefor |
| 10/09/2008 | US20080249052 Synthetic mini/micro-dystrophin genes to restore nNOS to the sarcolemma |
| 10/09/2008 | US20080249025 Peptide fragments of p21; antiproliferative agents |
| 10/09/2008 | US20080249013 Immunogenic fragment of a Cripto fusion protein that is reactive with an antibody or T-cell that reacts with a given polypeptide sequence; polynucleotides, expression vectors, host cells, T-cell lines; diganosis, prevention, treatment of lung, colon, colorectal and breast cancers |
| 10/09/2008 | US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions |
| 10/09/2008 | US20080249008 Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor |
| 10/09/2008 | US20080249007 Lysine residue of analog acylated with a diacid; substituted for an amino acid residue in [N-epsilon(17-carboxyheptadecanoic acid)20 exendin-4(1-39)-amide; hyperglycemia, type 2 diabetes, impaired glucose tolerance, type 1 diabetes, obesity, hypertension, syndrome X, dyslipidemia, cognitive disorders |
| 10/09/2008 | US20080249004 Method of Modulating Cell Survival, Differentiation and/or Synaptic Plasticity |
| 10/09/2008 | US20080249000 Oil in water emulsion, dispersoid, hydrophobic of essential oils, oil-soluble flavors, colors, flavors, vitamins, polyunsaturated fatty acids, animal oils, vegetable oils, sucrose acetate isobutyrate, triglycerides; disperse hydrophobic material in hydrophilic in hydrophobic solvent |
| 10/09/2008 | US20080248997 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners |
| 10/09/2008 | US20080248996 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 10/09/2008 | US20080248992 Inactivated alpha-cobratoxin; neurotoxins affecting neurojunction, ion channels; inactive bioactive polypeptide of anti-immunodeficiency virus immunokine binding to a cellular protein that reduces HIV infection; identification of a biologic anticholinergic agent capable of binding to a cellular protein |
| 10/09/2008 | US20080248972 Laminating a protein non-adsorptive substance with a negative charge on a substrate surface with a positive charge; modifying the protein non-adsorptive surface into a protein adsorptive surface; and adsorbing a protein in the locally modified region |
| 10/09/2008 | US20080248959 Polypeptide with amino acid sequence including exogenous glycosylate sequence; libraries |
| 10/09/2008 | US20080248953 Applying purified polypeptide that is a bacteriocin and possesses plant growth and/or disease resistance promoting activity to a plant or plant seed |
| 10/09/2008 | US20080248588 Shrimp allergen, anti-shrimp allergen antibody, and use thereof |
| 10/09/2008 | US20080248574 Therapeutic polypeptide comprising cell entry doman for use in treatment of cell proliferative disorders; enhancing metastaic tumor sensitivity to oxidative stress |
| 10/09/2008 | US20080248568 Propagating pluripotent cells in nutrient broth, activating notch signaling, recovering nervous system tissues; tissue engineering and regenerative medicine |
| 10/09/2008 | US20080248565 Isolated phospholipid-protein particles |
| 10/09/2008 | US20080248564 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 10/09/2008 | US20080248545 Modified cytochrome p450 for use as tool in identifying carcinogenic agents |
| 10/09/2008 | US20080248538 From Pseudomonas putida or Pseudomonas marginalis strains; probes |
| 10/09/2008 | US20080248528 Erythrovirus and its applications |
| 10/09/2008 | US20080248525 Twin-Arginine translocation in bacillus |
| 10/09/2008 | US20080248510 Immunoglobulin receptor for use as evaualtive tool in measuring strength of receptor ligand affinity |
| 10/09/2008 | US20080248509 Method for diagnosis of alzheimer's disease with determination of lasp-1 immunoreactivity |
| 10/09/2008 | US20080248497 Multimeric immunoglobulin specific for rickettsia polypeptides; veterinary medicine; diagnosing flea borne infection in dogs |
| 10/09/2008 | US20080248496 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 10/09/2008 | US20080248495 Protease Activated Receptor (PAR) activating peptide for use as screening tool in identifying modulators for treatment of thrombosis |
| 10/09/2008 | US20080248491 Biomarker fragments for the detection of human bnp |
| 10/09/2008 | US20080248477 Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 10/09/2008 | US20080248476 Using presence of single nucleotide polymorphism in fibronectin gene as evaluative indicator of heart disorders |
| 10/09/2008 | US20080248475 Methods and Compositions for Modulating Gluconeogenesis Using PGC-1 |
| 10/09/2008 | US20080248460 Composition and method for modulating an inflammatory response |
| 10/09/2008 | US20080248188 maize starch,has an increased phosphate content and/or a modified phosphorylation pattern and/or an increased final viscosity in an RVA profile and/or a reduced peak temperature in DSC analysis and/or an increased gel strength in texture analysis compared with starch from non-genetically modified plant |
| 10/09/2008 | US20080248099 using insulin for making medicine to treat Alzheimer's disease, brain atrophy associated with diabetes, Parkinson's disease, Huntington's Disease, senile dementia, multiple sclerosis, dementia associated with Acquired Immunodeficiency Syndrome (AIDS), Pick's Disease, stroke, trauma; tolbutamide |
| 10/09/2008 | US20080248064 Localization and Characterization of Flavivirus Envelope Gylcoprotein Cross-Reactive Epitopes and Methods for their Use |
| 10/09/2008 | US20080248063 Hetero-Oligomeric Hiv Envelope Proteins |
| 10/09/2008 | US20080248057 Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation |
| 10/09/2008 | US20080248056 Immunomodulatory Product Obtained from a Bifidobacterium Culture and Compositions Containing the Same |
| 10/09/2008 | US20080248045 Polypeptides having a triggering nk activity and biological applications |
| 10/09/2008 | US20080248044 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination |
| 10/09/2008 | US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders |
| 10/09/2008 | US20080248040 Nucleotide sequences coding membrane protein segments for use in identifying modulators for prevention and treatment of epilepsy, cancer, pain and sleep disorders |
| 10/09/2008 | US20080248031 Cell surface molecule mediating cell adhesion and signal transmission |
| 10/09/2008 | US20080248010 Protein kinase for use as tool in identifying modulators for treatment of diabetes |
| 10/09/2008 | US20080248009 Using antisense agents specific to apoptosis-associated nucleic acids to modulate apoptosis in transplanted tissues; treating cell proliferative disorders |
| 10/09/2008 | US20080248008 Transferase inhibitory mimetic for use in treatment and prevention of immunosuppressive, cell proliferative and autoimmune disorders |
| 10/09/2008 | US20080248007 Nucleotide sequences coding protein associated with immune response for use in identifying modulators for prevention and treatment of immunodeficiency, autoimmue and inflammatory disorders |